SABINA TAVARES: Open Payments
NPI 1477064293 · EAST BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 41 payments from 9 companies in 2025. Trend: 2023 $1,449 · 2024 $1,284 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $379 |
| E.R. Squibb & Sons, L.L.C. | 5 | $145 |
| Otsuka America Pharmaceutical, Inc. | 7 | $138 |
| ABBVIE INC. | 5 | $114 |
| Janssen Pharmaceuticals, Inc | 5 | $92 |
| Lundbeck LLC | 3 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $79 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: CAPLYTA, REXULTI, COBENFY, VRAYLAR, INVEGA SUSTENNA, TRINTELLIX, AUSTEDO XR, Auvelity.
Industry payments across MA — which companies pay providers there.
